DARIOHEALTH CORP (DRIO)
US23725P2092 - Common Stock
Dario Publishes New Peer-Reviewed Study that Deepens the Body of Evidence that Managing Cardiometabolic Conditions in One Integrated Platform Improves Clinical Outcomes
/PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, announced today new research...
Dario Signs Two Employers for Cardiometabolic Suite with Integrated GLP-1 Solution
/PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, announced today two new contracts to...
Dario Publishes Two New Peer-Reviewed Studies Demonstrating Impact of Digital Behavioral Health
/PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, announced today two new studies...
Two National Employers Select Dario's Integrated Chronic Condition Solution to Improve Employee Health
/PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, announced today two new contracts to...
DRIO Stock Earnings: DarioHealth Beats EPS, Beats Revenue for Q4 2023
DRIO stock results show that DarioHealth beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023.
DarioHealth Reports Fourth Quarter and Full-Year 2023 Financial and Operating Results
Full-year 2023 revenue of $20.4 million reflects a decrease from 2022 revenue of $7.3 due to a managed decrease in B2C and strategic milestone revenue as the...
DARIOHEALTH TO REPORT FOURTH QUARTER 2023 RESULTS ON THURSDAY, MARCH 28TH
/PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced today that it will release its financial...
New Research from Dario Demonstrates Ability to Deliver Improved Health Outcomes with Integrated Solution for Members Managing Weight and Blood Glucose with or without GLP-1 Medications
/PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) (the "Company"), a leader in the global digital therapeutics (DTx) market, announced today two new clinical...
DARIOHEALTH TO PARTICIPATE IN THE COWEN 43RD ANNUAL HEALTHCARE CONFERENCE
/PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital health market, today announced that management will participate in the Cowen...
Dario acquires Twill creating one of the most comprehensive digital health platform across the most prevalent chronic conditions
/PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company") announced today that it has acquired Twill, Inc. ("Twill"), a leader in digital-led...
Regional Union Selects Dario's Cardiometabolic Solution for Diabetes, Hypertension, Weight Management and GLP-1 Support
/PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, announced today a new contract to...
El galardonado programa Wellvolution de Blue Shield of California, ahora más accesible para los hispanohablantes, suma un nuevo programa para la hipertensión
/PRNewswire-HISPANIC PR WIRE/-- Blue Shield of California está mejorando el acceso a su galardonada plataforma de salud digital Wellvolution para las personas...
Blue Shield of California's Award-Winning Wellvolution Now More Accessible for Spanish Speakers, Adds New Hypertension Offering
/PRNewswire/ -- Blue Shield of California is making its award-winning digital health platform Wellvolution more accessible for Spanish-speakers and expanding...
Dario secures contracts for cardiometabolic solution (NASDAQ:DRIO)
DarioHealth Corp signs a contract to offer its cardiometabolic solution to a national financial and business services company, with positive market...
Dario Contracts with New Employer for Cardiometabolic Solution
/PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, announced today a new contract to...
Dario Publishes New Research Demonstrating that Dario Users That Increased Physical Activity Can Maintain Reduced Blood Glucose
/PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, announced new research presented at...
DarioHealth Reports Third Quarter 2023 Financial and Operating Results
Third quarter total revenue of $3.52 million compared to $6.6 million in the third quarter of 2022, impacted mainly by lower commercial strategic partners...
Dario Launches Apple iPhone 15 Accessible Smart Blood Glucose Meter
/PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, announced the launch of a new smart...
DarioHealth to Report Third Quarter 2023 Results on Thursday, November 2nd
/PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital health market, today announced that it will release its financial results for...
New Research Shows 36% Reduction in 30-Day Hospital Readmission Rate for Dario Users with Type 2 Diabetes
/PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, announced today new research...
Dario Signs National Preferred Partner Agreement with a Top Five National Employee Benefits Consulting Firm
/PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, announced a new strategic...
DarioHealth to Host Investor Day on The Rise of Digital Health
/PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, announced that it will host an...
Dario Publishes New Research Demonstrating Clinically Significant Reductions in Depression Through its Digital Behavioral Health Programs
/PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, announced new research published in...
Dario Publishes New Research Demonstrating Greater Engagemenet and Improved Clinical Outcomes Sustainable for Two Years
/PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, announced new research presented at...
Dario Partners with PlanSource to Offer Employers Easy Access to Proven Digital Health Solutions
/PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, announced a new agreement with...